The situation of antibiotic usage and antibiotic resistance in the treatment of community-acquired pneumonia at Can Tho City General Hospital

Abstract

Community-acquired pneumonia is a fatal disease in all age groups. The objective of the study was to survey the clinical characteristics of patients, and to assess the antibiotic resistance of community-acquired pneumonia-causing bacteria at Can Tho City General Hospital in 2021. Cross-sectional and retrospective descriptive study design was applied to the medical records of 332 patients. The results of the study showed that the highest rate of comorbidities was respiratory disease 36%, followed by cardiovascular disease 32%. Antibiograms showed that amikacin was sensitive to bacteria (32,5%), as Ertapenem and imipenem were (22,5%), Ampicillin, ciprofloxacin and levofloxacin were the lowest (5%). The study recorded 42,5% of bacteria resistant to ciprofloxacin and (40%) of bacteria resistant to levofloxacin. Amikacin has a high rate of sensitivity to isolated pathogens. Quinolone antibiotics are the group of antibiotics with the highest rate of resistance by bacteria.